A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1998
10/14/1998	CN1195536A Plaster for curing hemiplegia, hypertension and contraception
10/14/1998	CN1195522A Use of 2(3) tertiary butyl-4-hydroxy-anisole in preparation of drug for preventing and curing tissue organ traumatic disease
10/14/1998	CN1040210C Fused benzazepine derivative and pharmaceutical composition containing the same
10/13/1998	US5821365 Compounds as enzyme inhibitors for kinases formed by reaction of amine with anhydride group to form indolmaleimide macrocycles
10/13/1998	US5821354 Synthesizing a dna sequence in at least two parts; labeling the 5' end of one with a radioisotope; hybridizing; ligating; useful to prevent uncontrolled cellular proliferation
10/13/1998	US5821267 Modulating the inducible isoform over the constitutive; hypertensive, antiarthritic and diabetic agents; therapy with cytokines; toxic and septic shock
10/13/1998	US5821262 Hydroxamic acid derivatives as inhibitors of cytokine production
10/13/1998	US5821256 Endothelin receptor antagonists
10/13/1998	US5821255 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
10/13/1998	US5821253 Tetrahydrobenzo a!fluorene compounds and methods of use
10/13/1998	US5821234 Administering an effective dosage of at least one antisense sequence to at least one gene expressing a cyclin or a cyclin dependent kinase which inhibits the expression of the gene
10/13/1998	US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998	US5821123 Modified antibody variable domains
10/13/1998	US5820587 Method and kit for preventing erectile dysfunction
10/08/1998	WO1998044128A1 Novel human serine carboxypeptidase
10/08/1998	WO1998044118A1 Chemokine beta-6
10/08/1998	WO1998044000A1 Recombinant protein c and protein s variants
10/08/1998	WO1998043963A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998	WO1998043959A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
10/08/1998	WO1998043947A1 Nitro-benzamide useful as anti-arrhythmic agent
10/08/1998	WO1998043945A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
10/08/1998	WO1998043694A1 Targeted therapy to a biomedical device
10/08/1998	WO1998043666A1 Antioxidant protein 2, gene and methods of use therefor
10/08/1998	WO1998043661A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
10/08/1998	WO1998043645A1 Inhibitors for the formation of glycosylated protein denaturation products
10/08/1998	WO1998043641A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties
10/08/1998	WO1998043631A1 Mixture of primary fatty acids obtained from sugar cane wax
10/08/1998	WO1998043630A1 Means of ascertaining an individual's risk profile for atherosclerotic disease
10/08/1998	WO1998043618A2 Use of cytoskeletal inhibitors for the prevention of restenosis
10/08/1998	WO1998020027A3 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
10/08/1998	WO1998018429A3 A method for lowering plasma levels of lipoprotein(a)
10/08/1998	CA2293359A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties
10/08/1998	CA2285631A1 Antioxidant protein 2, gene and methods of use therefor
10/08/1998	CA2285622A1 Chemokine beta-6
10/08/1998	CA2285372A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998	CA2285324A1 Targeted therapy to a biomedical device
10/08/1998	CA2285197A1 Nitro-benzamide useful as anti-arrhythmic agent
10/08/1998	CA2285091A1 Means of ascertaining an individual's risk profile for atherosclerotic disease
10/08/1998	CA2283934A1 Recombinant protein c and protein s variants
10/08/1998	CA2283799A1 Novel human serine carboxypeptidase
10/07/1998	EP0869180A1 A TNF homologue, TL5
10/07/1998	EP0869179A1 Tumor necrosis related receptor, TR7
10/07/1998	EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998	EP0869126A1 Dithiolan derivatives, their preparation and their therapeutic effect
10/07/1998	EP0869119A1 Phenoxymethyl piperidine derivatives being sodium channle blockers
10/07/1998	EP0869116A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicaments containing them
10/07/1998	EP0868428A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity
10/07/1998	EP0868191A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
10/07/1998	EP0868180A1 Endothelin receptor antagonists
10/07/1998	EP0868179A1 New use for losartan
10/07/1998	EP0724566B1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
10/07/1998	EP0720598B1 Phenoxyphenyl cyclopentenyl hydroxyureas
10/07/1998	EP0711271B1 Aminoindanes and related compounds useful as calcium-channel antagonists
10/07/1998	EP0649424B1 Dioxcyclobutene derivatives as angiotensin ii antagonists
10/07/1998	EP0621867B1 New endothelin antagonists and their preparation
10/07/1998	EP0558487B1 Piperidine compounds, their preparation and use
10/07/1998	CN1195353A New inhibitors of platelet aggregation
10/07/1998	CN1195295A Method and use of connective tissue growth factor as revellent
10/07/1998	CN1194982A Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
10/07/1998	CN1194979A Hypolipidemic 1,4-benzothiazepine-1, 1-dioxides
10/07/1998	CN1194977A Phenoxymethyl piperidine derivatives
10/07/1998	CN1194976A Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament, and medicament comprising them
10/07/1998	CN1194847A Ointment for treating hemorrhoid
10/07/1998	CN1040108C Process for preparing compound of benzyl indoles
10/07/1998	CN1040106C Process for preparing piperazine derivatives
10/07/1998	CN1040062C Process for preparing pharmacologically active catechol derivatives
10/06/1998	US5817796 C-myb ribozymes having 2'-5'-linked adenylate residues
10/06/1998	US5817698 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists
10/06/1998	US5817683 Naphthoic derivative; hypotensive agent
10/06/1998	US5817677 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation
10/06/1998	US5817676 Indazolecarboxamides
10/06/1998	US5817674 Antiotensin ii receptor antagonists
10/06/1998	US5817653 Endothelin receptor antagonists
10/06/1998	US5817652 Hypolipidaemic condensed 1,4-thiazepines
10/06/1998	US5817640 Acadesine
10/06/1998	US5817636 Genetic construct, radiation-responsive enhancer-promoter region
10/06/1998	US5817485 Nucleic acids and cells for recombinant production of fibroblast growth factor-10
10/06/1998	US5817461 Methods and compositions for diagnosis of hyperhomocysteinemia
10/06/1998	CA2167715C Heteroaryl cycloalkenyl hydroxyureas
10/03/1998	CA2232147A1 Phenoxymethyl piperidine derivatives
10/02/1998	CA2233787A1 Sialoadhesin family member-3
10/02/1998	CA2233785A1 Tumor necrosis related receptor, tr7
10/02/1998	CA2233682A1 Dithiolan derivatives, their preparation and their therapeutic effect
10/02/1998	CA2232743A1 A tnf homologue, tl5
10/02/1998	CA2226910A1 Sialoadhesin family member-2 (saf-2)
10/02/1998	CA2223021A1 Novel human neurotensin receptor type 2 and splice variants thereof
10/01/1998	WO1998042834A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998	WO1998042751A1 Oxidised fragments of apolipoprotein b and their use
10/01/1998	WO1998042739A2 Secreted proteins and polynucleotides encoding them
10/01/1998	WO1998042738A1 87 human secreted proteins
10/01/1998	WO1998042706A1 Method of making arylamino triazolopyridines
10/01/1998	WO1998042696A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
10/01/1998	WO1998042661A1 Aromatic and heterocyclic nitrato derivatives
10/01/1998	WO1998042358A1 Methods for treating vascular disorders
10/01/1998	WO1998042327A2 Vascular remodeling agent
10/01/1998	WO1998042209A1 Decaffeinated mate extracts and the use thereof
10/01/1998	WO1998024427A3 Compositions and methods for treating or preventing inflammatory diseases
10/01/1998	CA2284620A1 Dithiane and dithiolane nitrato derivatives
10/01/1998	CA2284550A1 87 human secreted proteins
10/01/1998	CA2284279A1 Methods for treating vascular disorders

1 ... 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 ... 1595